Silencing of PGK1 and ALDOA restores Th17 cell response to UCB in vitro, as reflected by an increase in the expression of immunoregulatory markers like the ectoenzyme CD39; and boosts UCB immunosuppressive properties in vivo, in an experimental model of colitis in humanized mice. This evidence concerns the gene ENTPD1 and colitis.